Hologic reports continued growth in second quarter of 2015

Hologic has announced strong financial results for the second quarter of its 2015 fiscal year, which ended on March 28th 2015.

The company's revenues for the quarter came to $655.5 million (427.28 million pounds), which represented an increase of 4.9 percent on a reported basis, or 7.2 percent on a constant currency basis.

Its non-GAAP earnings per share also increased by 10.8 percent to $0.41, meaning Hologic has now posted strong organic revenue growth across the board for a second straight quarter.

The firm's breast health, diagnostics and GYN surgical divisions all demonstrated improved performances, leading to an upward revision of its financial guidance for the full year.

Steve MacMillan, Hologic's president and chief executive officer, said: "While we focus on continuing to improve our performance, we are increasingly confident in our people and products, and are therefore further raising our financial outlook for the year."

The company previously achieved a 6.6 percent sales increase in the first quarter of the year, delivering a revenue total of $652.8 million.